tonabersat: Clinical Trials

5 trials of tonabersat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5

Follow tonabersat: new trials by email Literature Review of tonabersat trials Research Report on tonabersat

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Xiflamâ„¢ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC)
Tonabersat, Placebo - Long COVID
Phase 2CompletedInflammx Therapeutics Inc162024-03-122026-03-06
Evaluation of Tonabersat for DME
Tonabersat, Placebo - Diabetic Macular Edema
Phase 2CompletedJaeb Center for Health Research1292023-05-022026-11-20
Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Tonabersat, Placebo - Migraine Without Aura, Migraine With Aura
Phase 2CompletedMinster Research Ltd5422007-10-012009-03-31
Tonabersat in the Prophylaxis of Migraine With Aura
Tonabersat, Placebo - Migraine With Aura
Phase 2CompletedMinster Research Ltd392006-05-012009-08-31
Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Tonabersat, Placebo - Migraine Without Aura, Migraine With Aura
Phase 2CompletedMinster Research Ltd1242006-04-012009-08-31

Conditions studied

Migraine with Aura (3)  ·  Migraine without Aura (2)  ·  Post-Acute COVID-19 Syndrome (1)

Sponsors

Minster Research Ltd (3)  ·  Inflammx Therapeutics Inc (1)  ·  Jaeb Center for Health Research (1)

Countries

Denmark (2)  ·  United States (2)  ·  Hungary (1)  ·  South Africa (1)  ·  United Kingdom (1)

Top investigators

Jes Olesen, MD (1)  ·  Peter Chang, MD (1)  ·  Peter Goadsby, MD (1)  ·  Richard Lipton, MD (1)

Results publications

PMID 19222510, PMID 19570717

NIH funding

UG1EY014231 (1)